| Literature DB >> 28091786 |
Wioletta Adamus-Białek1, Łukasz Lechowicz2, Anna B Kubiak-Szeligowska3, Monika Wawszczak2, Ewelina Kamińska2, Magdalena Chrapek4.
Abstract
Bacterial drug resistance and uropathogenic tract infections are among the most important issues of current medicine. Uropathogenic Escherichia coli strains are the primary factor of this issue. This article is the continuation of the previous study, where we used Kohonen relations to predict the direction of drug resistance. The characterized collection of uropathogenic E. coli strains was used for microbiological (the disc diffusion method for antimicrobial susceptibility testing), chemical (ATR/FT-IR) and mathematical (artificial neural networks, Ward's hierarchical clustering method, the analysis of distributions of inhibition zone diameters for antibiotics, Cohen's kappa measure of agreement) analysis. This study presents other potential tools for the epidemiological differentiation of E. coli strains. It is noteworthy that ATR/FT-IR technique has turned out to be useful for the quick and simple identification of MDR strains. Also, diameter zones of resistance of this E. coli population were compared to the population of E. coli strains published by EUCAST. We observed the bacterial behaviors toward particular antibiotics in comparison to EUCAST bacterial collections. Additionally, we used Cohen's kappa to show which antibiotics from the same class are closely related to each other and which are not. The presented associations between antibiotics may be helpful in selecting the proper therapy directions. Here we present an adaptation of interdisciplinary studies of drug resistance of E. coli strains for epidemiological and clinical investigations. The obtained results may be some indication in deciding on antibiotic therapy.Entities:
Keywords: ATR/FT-IR; Differentiation; Drug resistance; UPEC
Mesh:
Year: 2017 PMID: 28091786 PMCID: PMC5310551 DOI: 10.1007/s11033-017-4099-y
Source DB: PubMed Journal: Mol Biol Rep ISSN: 0301-4851 Impact factor: 2.316
Fig. 1The example of infrared spectrum of uropathogenic E. coli strain (No. 41); windows 1—lipids, windows 2—proteins, windows 3—nucleic acids, windows 4—carbohydrates, windows 5—fingerprint region
The characteristics of artificial neural networks that recognize E. coli MDR strains
| No. | Network architecture | Error in learning group (%) | Error in testing group (%) | Error in validation group (%) | Learning algorithm | Error function | Activation function in hiden layer | Activation function in output layer |
|---|---|---|---|---|---|---|---|---|
| 1 | 50-8-2 | 3.54 | 8.92 | 7.87 | BFGS 156 | SOS | Exp | Linear |
| 2 | 50-9-2 | 3.2 | 9.19 | 8.92 | BFGS 158 | SOS | Exp | Linear |
| 3 | 50-10-2 | 3.66 | 7.87 | 8.92 | BFGS 123 | SOS | Exp | Tanh |
| 4 | 50-9-2 | 4.22 | 9.45 | 9.19 | BFGS 114 | SOS | Exp | Linear |
| 5 | 50-10-2 | 4.95 | 8.4 | 9.45 | BFGS 112 | SOS | Exp | Tanh |
| 6 | 50-8-2 | 6.86 | 9.45 | 9.71 | BFGS 156 | SOS | Exp | Exp |
| 7 | 50-9-2 | 5.91 | 10.24 | 9.71 | BFGS 136 | SOS | Exp | Exp |
| 8 | 50-9-2 | 4.44 | 8.66 | 9.71 | BFGS 102 | SOS | Exp | Linear |
| 9 | 50-10-2 | 3.6 | 7.61 | 9.97 | BFGS 128 | SOS | Exp | Linear |
BFGS broyden–fletcher–goldfarb–shanno algorithm, Exp exponential function, Tanh hyperbolic tangent function, SOS sum of square
Fig. 2The differentiation of the E. coli strains based on the inhibition zones diameters to particular antibiotics according to Ward’s agglomeration method
The characteristics of the dendrogram (Fig. 2)
| Cluster | No. of strains | All strains restistant to antibiotics (class) | All strains sensitive to | % of strains with virulence factors genes |
|---|---|---|---|---|
| 1 | 19 | Nalidixic acid (quinolones) | Mecillinam (penicillins); ampicillin.sulbactam (penicillin comb.); | 21 |
| 2 | 43 | Tigecycline (others) | Mecillinam (penicillins); ampicillin.sulbactam (penicillin comb.); | 67 |
| 3 | 15 | Amoxicillin, ampicillin, piperacylline, ticarcillin (penicillins); Ticarcillin.clavulanic.acid (penicillin comb.); | Doripenem, meropenem (carbapenems) | 13 |
| 4 | 30 | Tigecycline (others); | Meropenem, close to ertapenem (carbapenems) | 63 |
The coincidence up to 1 mm of growth inhibition zones between drug resistance profiles of each pair of all E. coli strains
| No. (%) of antibiotics | No. (%) of paired strains with 1 mm coincidence | ||
|---|---|---|---|
| 0 | (0) | 5 | (0.1) |
| 1 | (2.7) | 50 | (1) |
| 2 | (5.41) | 139 | (2.5) |
| 3 | (8.11) | 241 | (4.3) |
| 4 | (10.8) | 324 | (5.7) |
| 5 | (13.5) | 426 | (7.5) |
| 6 | (16.2) | 503 | (8.9) |
| 7 | (18.9) | 526 | (9.3) |
| 8 | (21.6) | 536 | (9.5) |
| 9 | (24.3) | 518 | (9.1) |
| 10 | (27) | 496 | (8.8) |
| 11 | (29.7) | 449 | (7.9) |
| 12 | (32.4) | 341 | (6) |
| 13 | (35.1) | 302 | (5.3) |
| 14 | (37.8) | 207 | (3.7) |
| 15 | (40.5) | 162 | (2.9) |
| 16 | (43.2) | 115 | (2) |
| 17 | (45.9) | 94 | (1.7) |
| 18 | (48.6) | 78 | (1.4) |
| 19 | (51.4) | 60 | (1.1) |
| 20 | (54.1) | 47 | (0.8) |
| 21 | (56.8) | 29 | (0.5) |
| 22 | (59.5) | 9 | (0.2) |
| 23 | (62.2) | 6 | (0.1) |
| 24 | (64.9) | 3 | (0.1) |
| 25 | (67.6) | 3 | (0.1) |
| 26 | (70.3) | 1 | (0.02) |
| 27 | (73) | 1 | (0.02) |
| 28 ≤ 37 | (74 ≤ 100) | 0 | (0) |
Fig. 3The examples of inhibition zone distributions among studied E. coli strains with an appropriate disc potency. Each example represents an identified bacterial behavior group: Sensitive (1), Coming intermediate (2), Intermediate (3), Resistant (5), Diverse (6) described in Table 1. The behavior groups were designed based on the highest peak of strain distribution in the zones of sensitivity (1), intermediate (3), resistance (5), on the border between the zones (2, 4). Diverse group (6) represents more than one identified peak of frequency of strains
The bacterial behavior groups to particular antibiotics characterized for the collection of reference E. coli strains (EUCAST) and for the studied E. coli strains based on the pattern in Fig. 3
| Group | Bacterial behavior | Antibiotics (reference | Antibiotics (studied |
|---|---|---|---|
| 1 | Sensitive | Amoxicillin, amikacin, | Ampicillin.sulbactam, |
| 2 | Coming intermediate |
| Amikacin, |
| 3 | Intermediate |
| Cefoxitin, gentamicin, netilmicin, |
| 4 | Coming resistant | none | none |
| 5 | Resistant | none | Tigecycline |
| 6 | Diverse |
| Amoxicillin, |
Bolded text similarities between strains collections
Fig. 4The synergistic effect of antibiotics detected by Cohen’s kappa correlation; A—penicillins, B—second generation of fluoroquinolones, C—first and third generation of caphalosporins, D—fourth generation of fluoroquinolones. The correlation is statistically significant (P < 0.05, Wald test)
The contrary effect of antibiotics from the same class detected by Cohen’s kappa
| Class | Antibiotic | Alterable with | |
|---|---|---|---|
| Penicillins | Mecillinam | Each other | Amoxicillin.clavulanate, ampicillin_sulbactam, piperacillin.tazobactam |
| Amoxicillin | Mecillinam | ||
| Ampicillin | |||
| Ticarcillin | |||
| Piperacylline | All penicillin comb | ||
| Penicillin combinations | Amoxicillin.Clavulanate | Each other | Each penicillins |
| Ampicillin_sulbactam | |||
| Piperacillin.tazobactam | |||
| Ticarcillin.clavulanic.acid | Piperacylline | ||
| Cephalosporins 2 | Cefoxitin | Each other | |
| Cefuroxime | |||
| Cephalosporins 3 | Cefixime | All cephalosporins 3 | |
| Cefotaxime | |||
| Ceftazidime | Cefixime, cefotaxime | ||
| Ceftibuten | Cefixime, cefotaxime, ceftriaxone | ||
| Ceftriaxone | Cefixime, cefotaxime, ceftibuten | ||
| Quinolones | Ciprofloxacin | Levofloxacin, moxifloxacin | |
| Levofloxacin | Ciprofloxacin, norfloxacin, ofloxacin | ||
| Moxifloxacin | Ciprofloxacin, norfloxacin, ofloxacin | ||
| Norfloxacin | Levofloxacin, moxifloxacin | ||
| Ofloxacin | Levofloxacin, moxifloxacin | ||
| Aminoglycosides | Amikacin | Gentamicin, tobramycin | |
| Gentamicin | Amikacin, tobramycin | ||
| Tobramycin | Amikacin, gentamicin | ||
| Netilmicin |
| ||
| Others | Chloramphenicol | Fosfomycin | |
| Fosfomycin | Chloramphenicol | ||
| Tigecycline |
| ||
The correlation is statistically significant (P < 0.05, Wald test)